Gene · 4017
Papers2,536
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
481 to 500 of 2,536
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Non-alcoholic Fatty Liver Disease (NAFLD), Type 2 Diabetes, and Non-viral Hepatocarcinoma: Pathophysiological Mechanisms and New Therapeutic Strategies. | Biomedicines | 2023 | 36831004 | PubTator, text mining | PubMed |
| Escin's Multifaceted Therapeutic Profile in Treatment and Post-Treatment of Various Cancers: A Comprehensive Review. | Biomolecules | 2023 | 36830684 | PubTator, text mining | PubMed |
| Copper Exposure Induces Epithelial-Mesenchymal Transition-Related Fibrotic Change via Autophagy and Increase Risk of Lung Fibrosis in Human. | Antioxidants (Basel) | 2023 | 36830091 | PubTator, text mining | PubMed |
| Extracellular Vesicles as Regulators of the Extracellular Matrix. | Bioengineering (Basel) | 2023 | 36829629 | PubTator, text mining | PubMed |
| Hepatic Stellate Cells: Dictating Outcome in Nonalcoholic Fatty Liver Disease. | Cell Mol Gastroenterol Hepatol | 2023 | 36828280 | PubTator, text mining | PubMed |
| Temporal application of lysyl oxidase during hierarchical collagen fiber formation differentially effects tissue mechanics. | Acta Biomater | 2023 | 36822485 | PubTator, text mining | PubMed |
| Transcriptome analysis creates a new era of precision medicine for managing recurrent hepatocellular carcinoma. | World J Gastroenterol | 2023 | 36816628 | PubTator, text mining | PubMed |
| VE-Cadherin modulates β-catenin/TCF-4 to enhance Vasculogenic Mimicry. | Cell Death Dis | 2023 | 36797281 | PubTator, text mining | PubMed |
| The mechanical phenotypic plasticity of melanoma cell: an emerging driver of therapy cross-resistance. | Oncogenesis | 2023 | 36774337 | PubTator, text mining | PubMed |
| Research Progress of Tumor Microenvironment Targeted Therapy for Clear Cell Renal Cell Carcinoma. | Cancer Control | 2023 | 36772805 | PubTator, text mining | PubMed |
| The Roles of Epigenetic Regulation and the Tumor Microenvironment in the Mechanism of Resistance to Systemic Therapy in Hepatocellular Carcinoma. | Int J Mol Sci | 2023 | 36769116 | PubTator, text mining | PubMed |
| The Effects of the Follicle-Stimulating Hormone on Human Follicular Fluid-Derived Stromal Cells. | Int J Mol Sci | 2023 | 36768772 | PubTator, text mining | PubMed |
| Proteins Found in the Triple-Negative Breast Cancer Secretome and Their Therapeutic Potential. | Int J Mol Sci | 2023 | 36768435 | PubTator, text mining | PubMed |
| The Landscape of Secondary Genetic Rearrangements in Pediatric Patients with B-Cell Acute Lymphoblastic Leukemia with t(12;21). | Cells | 2023 | 36766699 | PubTator, text mining | PubMed |
| Cancer-Associated Adipocytes and Breast Cancer: Intertwining in the Tumor Microenvironment and Challenges for Cancer Therapy. | Cancers (Basel) | 2023 | 36765683 | PubTator, text mining | PubMed |
| Cell-Type-Specific Signalling Networks Impacted by Prostate Epithelial-Stromal Intercellular Communication. | Cancers (Basel) | 2023 | 36765657 | PubTator, text mining | PubMed |
| Targeting and regulation of autophagy in hepatocellular carcinoma: revisiting the molecular interactions and mechanisms for new therapy approaches. | Cell Commun Signal | 2023 | 36759819 | PubTator, text mining | PubMed |
| Liver stiffness thresholds to predict disease progression and clinical outcomes in bridging fibrosis and cirrhosis. | Gut | 2023 | 36750244 | PubTator, text mining | PubMed |
| Engineered Platforms for Maturing Pluripotent Stem Cell-Derived Liver Cells for Disease Modeling. | Cell Mol Gastroenterol Hepatol | 2023 | 36738860 | PubTator, text mining | PubMed |
| Integrated single-cell and bulk RNA sequencing analysis identifies a cancer-associated fibroblast-related gene signature for predicting survival and therapy in gastric cancer. | BMC Cancer | 2023 | 36717783 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4017/papers?page=25